Fibronostics will be at the EASL2023 congress in Vienna!

Fibronostics will be guests at the EASL congress in Vienna, Austria to present ‘NAFLD: Diagnostics and non-invasive assessment’.

Join Dr. Mona Munteanu, our Chief Scientific Officer, on 24 June between 09:00 – 17:00 where she will discuss ‘LIVERSTAT, first-line screening tool in at-risk MAFLD patients outperforms the standard-of-care (SOC) FIB-4’

We can’t wait to network with others in the industry, learn more about advancements in liver health, and take home knowledge we can apply to our current processes.

Find out more: